Literature DB >> 29356245

Predicting survival of older community-dwelling individuals according to five estimated glomerular filtration rate equations: The InChianti study.

Andrea Corsonello1, Claudio Pedone2, Stefania Bandinelli3, Luigi Ferrucci4, Raffaele Antonelli Incalzi2,5.   

Abstract

AIMS: There is uncertainty about which estimated glomerular filtration rate eGFR equation to use in older people with respect to the prediction of prognosis. Our aim was: (i) to compare the discriminative capacity of eGFR estimated by different equations with respect to all-cause mortality; and (ii) to identify the eGFR threshold at which the risk of mortality starts to increase for each equation.
METHODS: We used data from 828 community-dwelling older adults aged >65 years enrolled in the InCHIANTI study. The outcome measure was all-cause mortality at 9 years. GFR was estimated by five different equations: Chronic Kidney Disease Epidemiological Collaboration (creatinine equation [CKD-EPIcre ], and creatinine and cystatin C equation [CKD-EPIcre-cys ]), Berlin Initiative Study (BIScre and BIScre-cys ) and full age spectrum. Sensitivity, specificity, areas under receiver operating curve (AUC) and C-statistics were used to compare their predictive capacity.
RESULTS: The best mix of sensitivity, specificity, AUC and C-statistic value in predicting mortality was observed with BIS equations. BIScre (AUC 0.65, 95% CI 0.61-0.69) outperformed both CKD-EPIcre (AUC 0.60, 95% CI 0.56-0.64; P = 0.005) and full age spectrum (AUC 0.63, 95% CI 0.59-0.67; P = 0.002) in terms of predictivity. Similarly, BIScre-cys (AUC 0.67, 95% CI 0.63-0.71) outperformed CKD-EPIcre-cys (AUC 0.63, 95% CI 0.59-0.67; P = 0.01). AUC obtained with equations also including cystatin C were not significantly different compared with their creatinine-based counterparts. The risk of long-term mortality began to increase at under 65.6 mL/min/1.73 m2 for CKD-EPIcre-cys , 60.5 for CKD-EPIcre , 60 for BIScre-cys , 56.3 for BIScre and 55.2 for full age spectrum.
CONCLUSIONS: The BIS equation discriminates the risk of all-cause mortality better than other equations in older community-dwelling individuals. The eGFR threshold under which mortality starts to increase could change as a function of the equation used. Geriatr Gerontol Int 2018; 18: 607-614.
© 2018 Japan Geriatrics Society.

Entities:  

Keywords:  Berlin Initiative Study; Chronic Kidney Disease Epidemiological Collaboration; estimated glomerular filtration rate; full age spectrum; mortality

Mesh:

Year:  2018        PMID: 29356245      PMCID: PMC5891358          DOI: 10.1111/ggi.13225

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  28 in total

1.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

Authors:  S KATZ; A B FORD; R W MOSKOWITZ; B A JACKSON; M W JAFFE
Journal:  JAMA       Date:  1963-09-21       Impact factor: 56.272

2.  Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects.

Authors:  Francesco Pizzarelli; Fulvio Lauretani; Stefania Bandinelli; Gwen B Windham; Anna Maria Corsi; Sandra V Giannelli; Luigi Ferrucci; Jack M Guralnik
Journal:  Nephrol Dial Transplant       Date:  2008-11-06       Impact factor: 5.992

3.  Estimated GFR and Mortality in Older Men: Are All eGFR Formulae Equal.

Authors:  Muna T Canales; Terri Blackwell; Areef Ishani; Brent C Taylor; Allyson Hart; Elizabeth Barrett-Connor; Cora Lewis; Rebecca J Beyth; Katie Stone; Kristine E Ensrud
Journal:  Am J Nephrol       Date:  2016-05-12       Impact factor: 3.754

4.  GFR estimation using cystatin C is not independent of body composition.

Authors:  Jamie Macdonald; Samuele Marcora; Mahdi Jibani; Gareth Roberts; Mick Kumwenda; Ruth Glover; Jeffrey Barron; Andrew Lemmey
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

5.  Cystatin C and long-term mortality among subjects with normal creatinine-based estimated glomerular filtration rates: NHANES III (Third National Health and Nutrition Examination Survey).

Authors:  Cho-Kai Wu; Jou-Wei Lin; James L Caffrey; Man-Huei Chang; Juey-Jen Hwang; Yu-Sheng Lin
Journal:  J Am Coll Cardiol       Date:  2010-11-30       Impact factor: 24.094

6.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

7.  Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD.

Authors:  Nisha Bansal; Ronit Katz; Ian H De Boer; Carmen A Peralta; Linda F Fried; David S Siscovick; Dena E Rifkin; Calvin Hirsch; Steven R Cummings; Tamara B Harris; Stephen B Kritchevsky; Mark J Sarnak; Michael G Shlipak; Joachim H Ix
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-20       Impact factor: 8.237

8.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

Review 9.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Authors:  Lesley A Inker; Brad C Astor; Chester H Fox; Tamara Isakova; James P Lash; Carmen A Peralta; Manjula Kurella Tamura; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2014-03-16       Impact factor: 8.860

10.  Mortality Prediction in the Oldest Old with Five Different Equations to Estimate Glomerular Filtration Rate: The Health and Anemia Population-based Study.

Authors:  Sara Mandelli; Emma Riva; Mauro Tettamanti; Paolo Detoma; Adriano Giacomin; Ugo Lucca
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

View more
  8 in total

Review 1.  CKD: A Call for an Age-Adapted Definition.

Authors:  Pierre Delanaye; Kitty J Jager; Arend Bökenkamp; Anders Christensson; Laurence Dubourg; Bjørn Odvar Eriksen; François Gaillard; Giovanni Gambaro; Markus van der Giet; Richard J Glassock; Olafur S Indridason; Marco van Londen; Christophe Mariat; Toralf Melsom; Olivier Moranne; Gunnar Nordin; Runolfur Palsson; Hans Pottel; Andrew D Rule; Elke Schaeffner; Maarten W Taal; Christine White; Anders Grubb; Jan A J G van den Brand
Journal:  J Am Soc Nephrol       Date:  2019-09-10       Impact factor: 10.121

2.  Association between severe chronic kidney disease defined by cystatin-c and creatinine and clinical outcomes in an elderly population - an observational study.

Authors:  Joana Tavares; Josefina Santos; Filipa Silva; João Oliveira; Jorge Malheiro; Andreia Campos; António Cabrita
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

3.  Cystatin C and creatinine-based eGFR levels and their correlation to long-term morbidity and mortality in older adults.

Authors:  Karin Werner; Anders Christensson; Helen Legrand; Mats Pihlsgård; Gunnar Sterner; Sölve Elmståhl
Journal:  Aging Clin Exp Res       Date:  2018-12-17       Impact factor: 3.636

4.  Clinical and Prognostic Implications of Estimating Glomerular Filtration Rate by Three Different Creatinine-Based Equations in Older Nursing Home Residents.

Authors:  Ersilia Paparazzo; Silvana Geracitano; Vincenzo Lagani; Luca Soraci; Annalisa Cozza; Salvatore Cosimo; Francesco Morelli; Andrea Corsonello; Giuseppe Passarino; Alberto Montesanto
Journal:  Front Med (Lausanne)       Date:  2022-04-26

5.  The relevance of geriatric assessments on the association between chronic kidney disease stages and mortality among older people: a secondary analysis of a multicentre cohort study.

Authors:  Andrea Corsonello; Luca Soraci; Johan Ärnlöv; Axel C Carlsson; Regina Roller-Wirnsberger; Gerhard Wirnsberger; Francesco Mattace-Raso; Lisanne Tap; Francesc Formiga; Rafael Moreno-González; Tomasz Kostka; Agnieszka Guligowska; Rada Artzi-Medvedik; Itshak Melzer; Christian Weingart; Cornell Sieber; Fabrizia Lattanzio
Journal:  Age Ageing       Date:  2022-07-01       Impact factor: 12.782

6.  Design and methodology of the screening for CKD among older patients across Europe (SCOPE) study: a multicenter cohort observational study.

Authors:  Andrea Corsonello; Lisanne Tap; Regina Roller-Wirnsberger; Gerhard Wirnsberger; Carmine Zoccali; Tomasz Kostka; Agnieszka Guligowska; Francesco Mattace-Raso; Pedro Gil; Lara Guardado Fuentes; Itshak Meltzer; Ilan Yehoshua; Francesc Formiga-Perez; Rafael Moreno-González; Christian Weingart; Ellen Freiberger; Johan Ärnlöv; Axel C Carlsson; Silvia Bustacchini; Fabrizia Lattanzio
Journal:  BMC Nephrol       Date:  2018-10-11       Impact factor: 2.388

7.  Clinical Implications of Estimating Glomerular Filtration Rate with Three Different Equations Among Older People. Preliminary Results of the Project "Screening for Chronic Kidney Disease among Older People across Europe (SCOPE)".

Authors:  Andrea Corsonello; Regina Roller-Wirnsberger; Gerhard Wirnsberger; Johan Ärnlöv; Axel C Carlsson; Lisanne Tap; Francesco Mattace-Raso; Francesc Formiga; Rafael Moreno-Gonzalez; Christian Weingart; Cornel Sieber; Tomasz Kostka; Agnieszka Guligowska; Pedro Gil; Sara Lainez Martinez; Rada Artzi-Medvedik; Itshak Melzer; Fabrizia Lattanzio
Journal:  J Clin Med       Date:  2020-01-21       Impact factor: 4.241

8.  Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance : The screening for CKD among older people across Europe (SCOPE) study.

Authors:  Andrea Corsonello; Paolo Fabbietti; Francesc Formiga; Rafael Moreno-Gonzalez; Lisanne Tap; Francesco Mattace-Raso; Regina Roller-Wirnsberger; Gerhard Wirnsberger; Johan Ärnlöv; Axel C Carlsson; Christian Weingart; Ellen Freiberger; Tomasz Kostka; Agnieszka Guligowska; Pedro Gil; Sara Lainez Martinez; Itshak Melzer; Ilan Yehoshua; Fabrizia Lattanzio
Journal:  BMC Geriatr       Date:  2020-10-02       Impact factor: 3.921

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.